For instance, celecoxib, a non-steroidal anti-inflammatory drug [NSAID] that selectively inhibits COX-2, was shown to reduce the extent of familial adenomatous polyposis17, 18, a condition resulting in colorectal cancers in 100% of cases19. This evidence concerns the gene PTGS2 and colorectal cancer.